Stock listing

Shenzhen:000513 Livzon Pharmaceutical Group, Inc. (丽珠集团) 股价

Home listing (Shenzhen) of Livzon Pharmaceutical Group, Inc.

Follow Livzon Pharmaceutical Group, Inc. into a list and get an email when it puts out news.

Share price · SZSE:000513

¥27.95 CNY -0.08 (-0.3%)

Close on Oct 16, 2026

Ticker: Shenzhen:000513
Asset type: Stock
Sector: Health care
Industry: Pharmaceuticals
Exchange: Shenzhen
Currency: CNY

Latest news

Interim Report 2023

Aug 22, 2023

Interim Report 2022

Aug 9, 2022

2022 First quarterly report

Apr 21, 2022

Livzon Pharmaceutical was recognized as the National Enterprise Technology Center with High Scores

Apr 20, 2022

A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial

Apr 20, 2022

Rapid Test for 2019-nCoV-2 Antigen (Lateral Flow) approved by China NMPA.

Apr 20, 2022

V-01 as a Sequential Booster Can Produce Good Protection against Omicron ---- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma

Feb 18, 2022

Announcement on progress of the reorganization

May 12, 2021

Voluntary announcement launch of futures hedging activities by controlling subsidiaries

May 6, 2021

Cancellation of the repurchased h shares

May 6, 2021

All Livzon Pharmaceutical Group, Inc. news

Livzon Pharmaceutical Group, Inc. on 6ix

Sector: Health care
Industry: Pharmaceuticals
News releases: 14 in all · newest Aug 22, 2023 · oldest 2021

Where Livzon Pharmaceutical Group, Inc. is listed

Listing	Exchange	Country	Currency
Shenzhen:000513 丽珠集团 · Home listing · This page	Shenzhen	China	CNY
HKEX:1513 麗珠醫藥	HKEX	Hong Kong	HKD
LS Exchange:A1XCAW	LS Exchange	Germany	EUR
Lang & Schwarz:A1XCAW	Lang & Schwarz	Germany	EUR
Frankfurt:LP6	Frankfurt	Germany	EUR
OTC:LVZPF	OTC	United States	USD

Log in to ask 6ix AI your own questions about Livzon Pharmaceutical Group, Inc.